Cargando…

Quality of life in patients with primary biliary cholangitis: A cross-geographical comparison

BACKGROUND & AIMS: Several symptoms impair the quality of life (QoL) of patients with primary biliary cholangitis (PBC). They are reported to vary significantly in different countries. Aim of our study was to explore whether there is a geographical clustering that accounts for symptoms in PBC. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montali, Lorenzo, Gragnano, Andrea, Miglioretti, Massimo, Frigerio, Alessandra, Vecchio, Luca, Gerussi, Alessio, Cristoferi, Laura, Ronca, Vincenzo, D’Amato, Daphne, O’Donnell, Sarah Elizabeth, Mancuso, Clara, Lucà, Martina, Yagi, Minami, Reig, Anna, Jopson, Laura, Pilar, Sesé, Jones, Dave, Pares, Albert, Mells, George, Tanaka, Atsushi, Carbone, Marco, Invernizzi, Pietro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843515/ https://www.ncbi.nlm.nih.gov/pubmed/33554101 http://dx.doi.org/10.1016/j.jtauto.2021.100081

Ejemplares similares

New Therapeutic Targets in Autoimmune Cholangiopathies
por: Gerussi, Alessio, et al.
Publicado: (2020)

The Role of Epigenetics in Primary Biliary Cholangitis
por: Gerussi, Alessio, et al.
Publicado: (2022)

Primary Sclerosing Cholangitis: Burden of Disease and Mortality Using Data from the National Rare Diseases Registry in Italy
por: Carbone, Marco, et al.
Publicado: (2020)

LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary Cholangitis
por: Gerussi, Alessio, et al.
Publicado: (2022)

Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis
por: Overi, Diletta, et al.
Publicado: (2022)

Takayasu arteritis and primary sclerosing cholangitis: A casual association or different phenotypes of the same disease?
por: Mulinacci, Giacomo, et al.
Publicado: (2021)

Comment on “Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis”
por: Cristoferi, Laura, et al.
Publicado: (2020)

Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut‐Off Approach
por: Cristoferi, Laura, et al.
Publicado: (2021)

A National Hospital‐Based Study of Hospitalized Patients With Primary Biliary Cholangitis
por: Manno, Valerio, et al.
Publicado: (2019)

Neurosteroid Activation of GABA-A Receptors: A Potential Treatment Target for Symptoms in Primary Biliary Cholangitis?
por: Wetten, Aaron, et al.
Publicado: (2022)

New insights on the role of human leukocyte antigen complex in primary biliary cholangitis
por: Mulinacci, Giacomo, et al.
Publicado: (2022)

Artificial intelligence for precision medicine in autoimmune liver disease
por: Gerussi, Alessio, et al.
Publicado: (2022)

Coronavirus Disease 2019 in Autoimmune Hepatitis: A Lesson From Immunosuppressed Patients
por: Gerussi, Alessio, et al.
Publicado: (2020)

Real-world experience with obeticholic acid in patients with primary biliary cholangitis
por: D’Amato, Daphne, et al.
Publicado: (2021)

The inter‐relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis
por: Dyson, J. K, et al.
Publicado: (2016)

Reduction and stabilization of bilirubin with obeticholic acid treatment in patients with primary biliary cholangitis
por: Parés, Albert, et al.
Publicado: (2020)

The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study
por: Jones, David E.J., et al.
Publicado: (2022)

Clinical application of the GLOBE and United Kingdom‐primary biliary cholangitis risk scores in a trial cohort of patients with primary biliary cholangitis
por: Carbone, Marco, et al.
Publicado: (2018)

Work–Life Balance: Weighing the Importance of Work–Family and Work–Health Balance
por: Gragnano, Andrea, et al.
Publicado: (2020)

Changing Nomenclature for PBC: From ‘Cirrhosis' to ‘Cholangitis'
por: Beuers, Ulrich, et al.
Publicado: (2015)

Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis
por: Lleo, Ana, et al.
Publicado: (2016)

Predictors of serious adverse events and non‐response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid
por: De Vincentis, Antonio, et al.
Publicado: (2022)

Health Literacy Levels among Italian Students: Monitoring and Promotion at School
por: Velasco, Veronica, et al.
Publicado: (2021)

The Relationship between Work, Health and Job Performance for a Sustainable Working Life: A Case Study on Older Manual Employees in an Italian Steel Factory
por: Previtali, Federica, et al.
Publicado: (2022)

Early Molecular Stratification of High-risk Primary Biliary Cholangitis
por: Hardie, Claire, et al.
Publicado: (2016)

Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor Agonists
por: Abenavoli, Ludovico, et al.
Publicado: (2020)

Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence?
por: Lacetera, Rosanna, et al.
Publicado: (2022)

An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs
por: Cordell, Heather J., et al.
Publicado: (2021)

Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial
por: Jones, David, et al.
Publicado: (2023)

The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities
por: Binatti, Eleonora, et al.
Publicado: (2022)

Quantitation of the Rank-Rankl Axis in Primary Biliary Cholangitis
por: Lleo, Ana, et al.
Publicado: (2016)

The Prevalence of Anti-Hexokinase-1 and Anti-Kelch-Like 12 Peptide Antibodies in Patients With Primary Biliary Cholangitis Is Similar in Europe and North America: A Large International, Multi-Center Study
por: Norman, Gary L., et al.
Publicado: (2019)

Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021)

The National Audit of Primary Biliary Cholangitis (PBC) in the United Kingdom: Defining the Audit Dataset and Data Collection System
por: Burke, Laura, et al.
Publicado: (2022)

Immune-Mediated Drug-Induced Liver Injury: Immunogenetics and Experimental Models
por: Gerussi, Alessio, et al.
Publicado: (2021)

Human β-Defensin 2 in Primary Sclerosing Cholangitis
por: Chang, Cindy, et al.
Publicado: (2017)

A patient with primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis variant syndrome
por: Terziroli Beretta-Piccoli, Benedetta, et al.
Publicado: (2019)

Systematic review—pancreatic involvement in inflammatory bowel disease
por: Massironi, Sara, et al.
Publicado: (2022)

Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581]
por: Cordell, Heather J., et al.
Publicado: (2022)

Case Report: Hypomorphic Function and Somatic Reversion in DOCK8 Deficiency in One Patient With Two Novel Variants and Sclerosing Cholangitis
por: Saettini, Francesco, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_373hasdhr8ha2rjr9fgnh6uqui